Healthcare
Biotechnology
Technology

Acorda Therapeutics

$3.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.26 (8.87%) As of 1:54 PM EDT today
+$0.26 (8.87%) Today

Why Robinhood?

You can buy or sell ACOR and other stocks, options, ETFs, and crypto commission-free!

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. Read More The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Employees
474
Headquarters
Ardsley, New York
Founded
1995
Market Cap
140.87M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.89M
High Today
$3.21
Low Today
$2.88
Open Price
$2.93
Volume
1.31M
52 Week High
$29.75
52 Week Low
$2.27

Collections

Healthcare
Biotechnology
Technology
Health
Therapy
US
North America

ACOR News

ReutersAug 7

Edited Transcript of ACOR earnings conference call or presentation 1-Aug-19 8:30pm GMT

186

ACOR Earnings

-$1.06
-$0.24
$0.58
$1.40
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 30, After Hours

More ACOR News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.